Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Endpoints at JPM 2025: China, Trump 2.0, markets and more
Jan 10, 2025 · JPM agenda focuses on Trump 2.0 transition, market recovery & US-China dynamics, featuring talks with Sanofi's Ashrafian, ARCH's Nelsen, Scott Gottlieb & other leaders.
News – Endpoints News
Merck and Eisai reveal late-stage fail for Keytruda and Lenvima in gastroesophageal cancer
Endpoints Webinars
Life sciences marketers work with long sales cycles and products that require market education — which make webinars one of the most essential tools in the biopharma demand generation …
The Endpoints 100 survey: What are biopharma execs saying …
Dec 11, 2024 · We’ve asked our advisory group in the E100 about how things are shaping up at the FDA and HHS under the new Trump administration and what impact prospective changes …
Merck and Eisai reveal late-stage fail for Keytruda and Lenvima in ...
1 day ago · Merck's Keytruda and Eisai's Lenvima combo with chemo failed survival endpoint in gastroesophageal cancer study, but companies remain committed to combination approach
Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM.
Endpoints at #ASCO24
Jun 4, 2024 · An in-depth discussion featuring Endpoints News Reporter Lei Lei Wu, and the Director of the National Cancer Institute, W. Kimryn Rathmell — covering her priorities in her …
Endpoints 11 | Biopharma's Most Promising Startups in 2020
The biggest healthcare crisis in 100 years has made biopharma the place to be, and with that backdrop we unveil the top 11 companies supercharging a new generation of startups in 2020. …
With Sam Altman’s help, Retro Biosciences eyes $1B to extend …
1 day ago · Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed in a Friday email to Endpoints News.